Evidence map›Paper›PMID 32699256›Full record

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2021

Cervical carcinomas with serous-like papillary and micropapillary components: illustrating the heterogeneity of primary cervical carcinomas.

Richard Wing-Cheuk Wong, Joshua Hoi Yan Ng, Kam Chu Han, Yuen Ping Leung, Chiu Man Shek, Kin Nam Cheung, Carmen Ka Man Choi, Ka Yu Tse, Philip P C Ip

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Richard Wing-Cheuk WongDepartment of Clinical Pathology, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong. wwc091@ha.org.hk.
Joshua Hoi Yan NgDepartment of Clinical Pathology, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong.
Kam Chu HanDepartment of Clinical Pathology, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong.
Yuen Ping LeungDepartment of Clinical Pathology, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong.
Chiu Man ShekDepartment of Clinical Pathology, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong.
Kin Nam CheungDepartment of Clinical Pathology, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong.
Carmen Ka Man ChoiDepartment of Obstetrics & Gynecology, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong.
Ka Yu TseDepartment of Obstetrics & Gynecology, The University of Hong Kong, Pokfulam, Hong Kong.
Philip P C IpDepartment of Pathology, The University of Hong Kong, Pokfulam, Hong Kong.ORCID http://orcid.org/0000-0002-0493-9838
Pamela Youde Nethersole Eastern Hospital · CNUniversity of Hong Kong · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent changes in the classification of cervical adenocarcinomas have re-categorized serous carcinoma as potentially nonexistent. However, clinical and pathological profiles of cervical adenocarcinomas with serous-like morphological features have not been systematically evaluated using the latest taxonomy and biomarkers. We studied 14 cases of primary cervical carcinomas with serous-like morphologies (papillary and micropapillary patterns). None of these cases exhibited evidence of serous carcinoma involving the upper tracts. Patient ages ranged between 34 and 86 years, most presented with abnormal uterine bleeding. Histologically, ten cases were classified as human papillomavirus (HPV)-associated carcinomas (eight usual-type endocervical adenocarcinomas and two adenosquamous carcinomas), of which six exhibited a papillary pattern and four had a micropapillary pattern. The four remaining cases were HPV-independent gastric-type adenocarcinomas, which displayed a papillary pattern in one case and a micropapillary pattern in three others. All ten HPV-associated carcinomas displayed block positive p16 and wild-type p53 by immunohistochemistry, with nine of them confirmed by HPV testing. Two of the four gastric-type adenocarcinomas had mutation-type p53, one of which also being p16 block positive. HER2 overexpression was demonstrated in 3/14 (21.4%) cases (2 HPV-associated and 1 HPV-independent). PD-L1 expression was identified in 4/10 (40%) cases, all HPV-associated. Targeted next-generation sequencing was performed in two cases with a micropapillary pattern, revealing a missense variant in ATM in an HPV-associated tumor and missense variants in TP53 and SMARCB1 in an HPV-independent tumor. The results demonstrated that primary endocervical adenocarcinomas can mimic the appearance of serous carcinoma, while not representing serous carcinoma. Serous-like papillary and micropapillary patterns may be present in both HPV-associated and HPV-independent cervical carcinomas, but none of the cases studied were unequivocally serous upon detailed analysis. Our findings support the exclusion of "cervical serous carcinoma" from existing classifications of cervical adenocarcinoma.

Indexed as

Adenocarcinoma, PapillaryAdultAgedAged, 80 and overAlphapapillomavirusBiomarkers, TumorBiopsyCarcinoma, AdenosquamousDNA Mutational AnalysisFemaleHumansImmunohistochemistryMiddle AgedMutation, MissenseNeoplasms, Cystic, Mucinous, and SerousPredictive Value of TestsBiomarkers, Tumor

Identifiers

PMID32699256
OpenAlexW3045139523

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.